be_ixf;ym_202004 d_10; ct_50 Skip to content

Pharmaceuticals Firm of the Year

ALM and The National Trial Lawyers have named Motley Rice Firm of the Year in its pharmaceutical litigation category.

Read about this award

Asbestos-Related Disease

Represented thousands of asbestos victims throughout the United States

You may have a claim

Leaders in Securities Fraud Litigation

Protecting U.S. and foreign plaintiffs

Learn More

Leading Complex Legal Battles

From opioid litigation and dangerous Takata airbags, to securities fraud, asbestos, and medical drugs and devices

Learn More

Current Cases

Active Case

Paragard IUD Lawsuit

When choosing an intrauterine device (IUD) as your form of birth control, you rely on manufacturers to provide safe, dependable products, and to be forthcoming about the severity of potential risks. However, thousands of women and health professionals have reported severe complications, including at least 15 deaths to the FDA, allegedly caused by Paragard®.

More Information

Headlines

March 30, 2020

Loestrin antitrust litigation settlement reached

Motley Rice, as co-lead and trial counsel for end-payor plaintiffs, helped reach a $62.5 million class action settlement to resolve claims alleging pharmaceutical drug manufacturers engaged in anticompetitive conduct to delay market entry of generic Loestrin 24 FE.

Read More

March 6, 2020

Replacement Takata airbags recalled

Airbag manufacturer Takata Corp., announced yet another major recall of 10 million potentially defective airbag inflators, the latest in a series that amounted to the largest automotive recall in U.S. history.

Read More

Recent Blog Posts